If biosolutions are ready, why are legacy regulatory systems still slowing their path into the real world?
In this second part of a three-part series, we examine the role regulation plays in the pace of biosolutions adoption. It explores how governance, risk perception, and regulatory systems influence innovation, while recognizing that the primary purpose of these systems — safeguarding people and the environment — must never be compromised. At the same time, it considers why identifying smarter ways to support innovation within these protective frameworks is becoming increasingly important.
Biosolutions hold immense potential. They are already deployed across multiple industries producing a wide range of everyday products. The scientific and policy literature on their promise is extensive, and rapid advances in biotechnology continue to expand that potential. Yet their widespread adoption continues to lag behind.
This audio article is part of The Biosolutions Bulletin. For the text version of this article and to get The Biosolutions Bulletin delivered monthly directly to your inbox, please go to: https://www.novonesis.com/en/biosolutions-bulletin
Podden och tillhörande omslagsbild på den här sidan tillhör
Novonesis. Innehållet i podden är skapat av Novonesis och inte av,
eller tillsammans med, Poddtoppen.